A5034583203- Endometrial and Cervical Cancer Treatments
- Ovarian cancer diagnosis and treatment
- Cervical Cancer and HPV Research
- Cancer Risks and Factors
- Gestational Diabetes Research and Management
- Diabetes Management and Research
- COVID-19 and healthcare impacts
- Uterine Myomas and Treatments
- Economic and Financial Impacts of Cancer
- Sex and Gender in Healthcare
- Endometriosis Research and Treatment
- Global Cancer Incidence and Screening
- Bone health and treatments
- Diabetes Treatment and Management
- Lymphoma Diagnosis and Treatment
- Reproductive System and Pregnancy
- Management of metastatic bone disease
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- PARP inhibition in cancer therapy
- Bariatric Surgery and Outcomes
- Male Breast Health Studies
Case Western Reserve University
2023
Case Comprehensive Cancer Center
2023
The Ohio State University
2019-2021
The Ohio State University Wexner Medical Center
2020
•Extreme obesity may preclude patients from primary surgical management of endometrial cancer.•Bariatric surgery is a safe and effective method rapid weight loss in with extreme obesity.•Delayed hysterectomy, after bariatric surgery, an option select cancer.
•Low grade serous (LGS) ovarian cancer is an uncommon cancer.•Androgen receptor expression testing not routinely performed in patients with LGS cancer.•Systemic androgen levels may be elevated PCOS or those taking exogenous testosterone.•Consideration should made to include for these patients.
INTRODUCTION: Previous literature suggests that patients with type 1 diabetes (T1DM) utilizing continuous subcutaneous insulin infusion (CSII) have lower hemoglobin A1c values compared to multiple daily injections (MDI). Despite improved glycemic control, rates of large for gestational age (LGA) infants are not different between these groups. This study investigates differences in profiles CSII and MDI glucose logs. METHODS: Retrospective cohort all singleton pregnancies complicated by T1DM...
INTRODUCTION: This study aimed to describe insulin dose changes throughout pregnancy by delivery method. METHODS: was a retrospective cohort of patients with T1DM in who delivered at large academic tertiary medical center from 2012 2016. Prescribed bolus and basal doses were extracted the record three time points: early (<20 weeks), mid (28-32 delivery. The primary outcome compared method (multiple daily injections [MDI] vs. continuous infusion [CSII]). Secondary outcomes percent change...